1.Product description
(1)Product name:CTnI One Step Troponin I Rapid Test Kit 
(2)Specification:Lateral-flow Immunofluorescence Chromatographic Assay 10 pcs, 25 pcs, 50 pcs, 100 pcs/box, or customized
(3)Analytical Range:1.0~50ng/ml (Whole Blood); 0.1~50ng/ml (Serum/Plasma)
2.Clinical significance
(1)Diagnosis of various chest pain
(2)Foundation of ACS diagnosis and risk stratification
(3)Best markers for ACS prognosis
(4)An aid in the diagnosis of myocardial infarction (injury)
(5)Can improve clinical, economic and operational outcomes

Hangzhou Laihe Biotech Co., Ltd. (hereafter referred to as “Laihe Biotech”) is a life science company specialized in R & D, manufacturing, marketing and service in point-of-care testing, monitoring and health technology industry, is committed to provide fast, accurate and reliable health detection products and services. Founded by Dr returned from United States in February 2012, today Laihe Biotech have a team of experienced scientists researching and developing diagnostic products, and have already built an independent POCT platform which including various rapid test products like Cardiac Marker Series (cTnI, NT-proBNP, H-FABP, etc.), Inflammation Series (hs-CRP, PCT, etc.), Tumor Marker Series (AFP, CEA, etc.), Diabetes Monitoring Series (HbA1c), Fertility Series (TORCH) and Infectious Diseases Series.